Table 1.
List of lncRNAs whose expression has been downregulated in SLE patients (PBMC: peripheral blood mononuclear cell, SPF BALB/c mice: specific pathogen-free (SPF) bcl-2 transgenic BALB/c mice).
LncRNA | Number of Clinical Samples (Tissues, Serum, etc.) | Assessed Cell Line | Targets/Regulators | Signaling Pathways | Function and Comments | Reference |
---|---|---|---|---|---|---|
lnc-HSFY2-3:3 | 15 SLE patients and 15 healthy donors were enrolled. | Monocyte-derived dendritic cells (moDCs) | [18] | |||
lnc-SERPINB9-1:2 | ||||||
GAS5 | 24 SLE patients and 12 healthy controls were enrolled. | Plasma | GAS5 induces apoptosis and growth arrest in human peripheral blood T cells and increases apoptosis. | [20] | ||
lnc-DC | STAT3 | Lnc-DC, which is expressed exclusively in dendritic cells, supports their capacity to stimulate T cell activation. | ||||
PRSS30P | 5 SLE patients and 6 age- and gender-matched normal individuals were enrolled in this study. | Plasma | [21] | |||
RP11-23P13.6 | ||||||
ARRDC1-AS1 | ||||||
RP4-758J18.2 | CCNL2 | The downregulation of RP4-758J18.2 and CCNL2 may play a key role in the immune response of SLE. | ||||
RP11-66N24.3 | ||||||
LINC00996 | REPIN1 | |||||
RP11-649A18.12 | NUP85, MIF4GD | |||||
RP11-539L10.2 | MAN2B2 | |||||
RP11-23J9.5 | ||||||
TMEM147-AS1 | ||||||
lnc5150 | 76 SLE patients and 71 healthy controls were recruited in this study. | PBMCs | Lnc5150 might disclose a diagnostic value for SLE. |
[23] | ||
linc0949 | Samples were obtained from 102 SLE patients and 76 healthy donors. | PBMCs | TNF-α, IL-6 | Linc0949 could be a potential biomarker for diagnosis, disease activity and therapeutic response in SLE. | [24] | |
CTC-471J1.2 | Samples were collected from 29 SLE patients and 34 age- and sex-matched healthy control subjects. | PBMCs | [19] | |||
TUG1 | Samples from 85 SLE patients and 95 healthy controls were collected. | PBMCs | miR-223 | TUG1 might be associated with inflammation and renal injury in SLE pathogenesis. | [26] | |
A total of 24 SPF BALB/c female mice (8 weeks old) (SLE models: n = 18, controls: n = 6). | Blood samples, kidney tissue | p65 | NF-κB signaling pathway | Inhibition of NF-κB signaling might be a potential target in SLE treatment. | [25] | |
SLEAR | 130 SLE patients and 119 healthy controls were enrolled. | Jurkat cells | ILF2, hnRNP F and TAF15 | SLEAR expression negatively correlates with degree of apoptosis in SLE patients. | [28] | |
uc001ykl.1 | 24 SLE patients and 12 age-matched healthy volunteers were recruited. | T cells | CDK6 | A decreased uc001ykl.1 level may induce CRISPLD2 downregulation and then result in inflammation and abnormalities of the erythrocyte sedimentation rate (ESR) and CRP. | [27] | |
ENST00000448942 | TNFSF10, TNFAIP3 | The correlation between ENST00000448942 and ESR may be due to its potential role in positively regulating expression of TNFAIP3, an important regulator of inflammation. |